Test Price
2,800 AEDโ Home Collection Available
BPIFA3 Gene Genetic Test for Autism Spectrum Disorder (ASD) in UAE | 2800 AED | DHA Licensed
Executive Summary & Core Metrics
High-Resolution NGS Analysis for Autism Susceptibility โ DHA Licensed, Clinically Actionable
- Diagnostic Precision: 99.9% coding region coverage via ISO-accredited next-generation sequencing; single-nucleotide resolution across the entire BPIFA3 gene.
- Patient-Centric Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection โ available daily from 8 AM to 11 PM across Dubai and the Northern Emirates.
- Post-Test Support: Telephonic clinical guidance provided by a Consultant Medical Geneticist to help families interpret results and plan next steps.
- Direct Billing Inquiry: Verify insurance coverage via WhatsApp +971 54 548 8731.
Test Overview & Methodology
The BPIFA3 (BPI fold containing family A member 3) gene test employs targeted next-generation sequencing to detect pathogenic and likely pathogenic variants associated with autism spectrum disorder susceptibility. This analysis is designed for UAE families seeking clinically actionable genetic insights and is performed under stringent ISO quality standards at DNA Labs UAE.
Our BPIFA3 NGS Test vs. Chromosomal Microarray Analysis
| Feature | BPIFA3 NGS Test | Chromosomal Microarray |
|---|---|---|
| Resolution | Single-nucleotide resolution; 99.9% coverage of BPIFA3 coding region | Detects large copy-number variants; may miss single-gene point mutations |
| Platform | Illumina NGS platform with clinical-grade validation | Microarray hybridization; limited base-pair resolution |
| Turnaround Time | 3 โ 4 weeks | 6 โ 8 weeks |
Physician Insight & Safety Protocols
โA BPIFA3 genetic finding should never be interpreted in isolation. The result must be integrated with a full developmental assessment by a paediatric neurologist, clinical geneticist, or developmental paediatrician. A negative result does not rule out autism; a positive variant indicates increased susceptibility, not a diagnosis. Early intervention guided by a genetics specialist delivers the greatest clinical benefit. Always consult your consultant before making any care decisions.โ
โ Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403
Advisory Notice โ Medication Steadfastness
โ ๏ธ Do not alter or discontinue any prescribed medication without direct consultation with your treating physician.
This genetic test provides susceptibility information and does not replace ongoing medical management or behavioural therapy.
Critical Safety Exclusions & Emergency Red Flags
- Exclusion โ Consent: Individuals who cannot provide informed consent (including minors without legally valid parental authorisation under Federal Decree-Law No. 4 of 2016 on Medical Liability) are not eligible for this test unless a legal guardian provides written approval.
- Exclusion โ Interfering Condition: Patients with a recent allogeneic bone marrow transplant or haematopoietic stem cell transplant; the donor-derived DNA in peripheral blood will confound germline genetic analysis. A buccal swab or fibroblast culture may be considered after specialist review.
- Emergency Red Flag โ Urgent Care Required: If the patient exhibits sudden, severe behavioural regression, new-onset self-harm, catatonia, or significant functional decline, seek immediate psychiatric or neurological evaluation โ do not wait for test results to arrive.
Patient FAQ & Clinical Guidance
1. What is the BPIFA3 gene and how does it relate to autism spectrum disorder?
The BPIFA3 gene encodes a protein implicated in neurodevelopmental signalling pathways. Pathogenic variants in this gene have been associated with increased susceptibility to autism spectrum disorder (ASD). This test identifies such variants through comprehensive sequencing of the geneโs coding regions.
2. Is this test suitable for children and what are the UAE legal requirements?
Yes, the test is suitable for children when ordered by a qualified physician. UAE law requires explicit parental or legal guardian consent for any genetic testing involving minors, in accordance with Federal Decree-Law No. 4 of 2016 on Medical Liability and Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL). Pre- and post-test genetic counselling is strongly recommended.
3. How is the sample collected and what logistics are involved?
A DHA-licensed phlebotomist visits your home or office using a temperature-controlled cold-chain kit. Peripheral whole blood is drawn, securely packaged, and transported to our ISO-certified laboratory in Dubai Healthcare City. The service operates daily from 8 AM to 11 PM, including weekends and public holidays.
4. What does a positive result mean for my family?
A positive result indicates a pathogenic variant that increases susceptibility to ASD โ it is not a diagnostic certainty. The finding should be discussed with a Consultant Medical Geneticist and a developmental paediatrician to guide early intervention, family screening, and long-term monitoring strategies.
UAE Regulatory & Data Privacy Adherence
๐ Data Protection & Health Information Governance
All genetic data generated by this test is processed and stored in compliance with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Patient consent, data minimisation, and secure transmission protocols are enforced at every stage.
DNA Labs UAE operates under DHA Facility License Number 1143 and adheres to the Dubai Health Authorityโs quality and safety standards for genetic testing and laboratory practice.
Clinical & Logistical Metadata
| Test Name | BPIFA3 Gene Sequencing for Autism Spectrum Disorder Susceptibility |
| Price (AED) | 2,800 AED |
| Turnaround Time | 3 โ 4 weeks (10 โ 14 business days) |
| Sample Type / Matrix | Peripheral Whole Blood (3โ5 mL in EDTA tube) |
| Methodology Used | Next Generation Sequencing (NGS) on Illumina Platform โ Targeted Gene Panel |
| ICD-10-CM Code | F84.0 (Autism Spectrum Disorder) |
| LOINC Code | 81317-3 (BPIFA3 gene mutation analysis in Blood or Tissue by NGS) |
| DHA Facility License & Laboratory Address | License No. 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE โ DNA Labs UAE |
ุฏุนู ุซูุงุฆู ุงููุบุฉ ู ุชุงุญ
ุงูุชุญูู ู ู ุงูุชุบุทูุฉ ุงูุชุฃู ูููุฉ
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
ุชููู ุนู ุงูุชุฎู ูู. ุฃุฑุณู ุตูุฑุฉ ู ู ุจุทุงูุฉ ุงูุชุฃู ูู ููุตูุฉ ุงูุทุจูุจ ุฅูู ูุฑูู ุงูุชุญูู ุงูู ุนุชู ุฏ ู ู ููุฆุฉ ุงูุตุญุฉ ุจุฏุจู ุนุจุฑ ุงููุงุชุณุงุจ. ุงุญุตู ุนูู ุชุญุฏูุซ ุงูุญุงูุฉ ูู ุฏูุงุฆู.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians